1
|
Pramanik P, Clulow R, Joshi DC, Stolpe A, Berastegui P, Sahlberg M, Mathieu R. Spin glass states in multicomponent layered perovskites. Sci Rep 2024; 14:3382. [PMID: 38336984 PMCID: PMC10858224 DOI: 10.1038/s41598-024-53896-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2023] [Accepted: 02/06/2024] [Indexed: 02/12/2024] Open
Abstract
Temperature-dependent dc-magnetization and ac-susceptibility curves have been recorded for series of single and double layered Ruddlesden-Popper multicomponent perovskites with chemical formula A2BO4 and A3B2O7, respectively, with (La, Sr) on A-sites and up to 7 different cations on the B-sites (Ti, Cr, Mn, Fe, Co, Ni, Cu). The phase purity and chemical homogeneity of the compounds were investigated by X-ray diffraction and energy dispersive X-ray spectroscopy. Independently of the composition, spin glassiness is observed in both systems. Scaling analyses suggest the materials undergo spin glass phase transitions at low temperatures. Yet, qualitative differences are observed between the single-layered and double-layered systems, which are discussed in the light of the spatial dimensionality and magnetic interaction in layered oxide perovskites.
Collapse
Affiliation(s)
- P Pramanik
- Department of Materials Science and Engineering, Uppsala University, Box 35, 751 03, Uppsala, Sweden.
| | - R Clulow
- Department of Chemistry - Ångström Laboratory, Uppsala University, Box 538, 751 21, Uppsala, Sweden
| | - D C Joshi
- Department of Materials Science and Engineering, Uppsala University, Box 35, 751 03, Uppsala, Sweden
| | - A Stolpe
- Department of Chemistry - Ångström Laboratory, Uppsala University, Box 538, 751 21, Uppsala, Sweden
- FSCN Research Centre, Surface and Colloid Engineering, Mid Sweden University, 851 70, Sundsvall, Sweden
| | - P Berastegui
- Department of Chemistry - Ångström Laboratory, Uppsala University, Box 538, 751 21, Uppsala, Sweden
| | - M Sahlberg
- Department of Chemistry - Ångström Laboratory, Uppsala University, Box 538, 751 21, Uppsala, Sweden
| | - R Mathieu
- Department of Materials Science and Engineering, Uppsala University, Box 35, 751 03, Uppsala, Sweden.
| |
Collapse
|
2
|
Peyrottes A, Rouprêt M, Fiard G, Fromont G, Barret E, Brureau L, Créhange G, Gauthé M, Baboudjian M, Renard-Penna R, Roubaud G, Rozet F, Sargos P, Ruffion A, Mathieu R, Beauval JB, De La Taille A, Ploussard G, Dariane C. [Early detection of prostate cancer: Towards a new paradigm?]. Prog Urol 2023; 33:956-965. [PMID: 37805291 DOI: 10.1016/j.purol.2023.09.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Accepted: 09/12/2023] [Indexed: 10/09/2023]
Abstract
Prostate cancer (PCa) is a public health issue. The diagnostic strategy for PCa is well codified and assessed by digital rectal examination, PSA testing and multiparametric MRI, which may or may not lead to prostate biopsies. The formal benefit of organized PCa screening, studied more than 10 years ago at an international scale and for all incomers, is not demonstrated. However, diagnostic and therapeutic modalities have evolved since the pivotal studies. The contribution of MRI and targeted biopsies, the widespread use of active surveillance for unsignificant PCa, the improvement of surgical techniques and radiotherapy… have allowed a better selection of patients and strengthened the interest for an individualized approach, reducing the risk of overtreatment. Aiming to enhance coverage and access to screening for the population, the European Commission recently promoted the evaluation of an organized PCa screening strategy, including MRI. The lack of screening programs has become detrimental to the population and must shift towards an early detection policy adapted to the risk of each individual.
Collapse
Affiliation(s)
- A Peyrottes
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, membre junior, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Service d'urologie, Hôpital Européen Georges-Pompidou, AP-HP Centre, Université de Paris, 20 rue Leblanc, 75015 Paris, France.
| | - M Rouprêt
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Sorbonne university, GRC 5 Predictive Onco-Uro, AP-HP, urology, Pitié-Salpétrière hospital, 75013 Paris, France
| | - G Fiard
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Department of urology, Grenoble Alpes university hospital, université Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, Grenoble, France
| | - G Fromont
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Department of pathology, CHRU, 37000 Tours, France
| | - E Barret
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Department of urology, institut mutualiste Montsouris, Paris, France
| | - L Brureau
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Department of urology, CHU de Pointe-à-Pitre, university of Antilles, university of Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), UMR S 1085, 97110 Pointe-à-Pitre, Guadeloupe
| | - G Créhange
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Department of radiotherapy, institut Curie, Paris, France
| | - M Gauthé
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Sintep nuclear medicine, 38100 Grenoble, France
| | - M Baboudjian
- Department of urology, La Conception Hospital, Aix-Marseille University, AP-HM, Marseille, France
| | - R Renard-Penna
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Sorbonne university, AP-HP, radiology, Pitie-Salpétrière hospital, 75013 Paris, France
| | - G Roubaud
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Department of medical oncology, institut Bergonié, 33000 Bordeaux, France
| | - F Rozet
- Sorbonne university, GRC 5 Predictive Onco-Uro, AP-HP, urology, Pitié-Salpétrière hospital, 75013 Paris, France; Department of urology, institut mutualiste Montsouris, Paris, France
| | - P Sargos
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Department of radiotherapy, institut Bergonié, 33000 Bordeaux, France
| | - A Ruffion
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Service d'urologie, centre hospitalier Lyon Sud, hospices civils de Lyon, Lyon, France
| | - R Mathieu
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Department of urology, CHU de Rennes, Rennes, France
| | - J-B Beauval
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Department of urology, La Croix du Sud Hôpital, Quint-Fonsegrives, France
| | - A De La Taille
- Department of urology, university hospital Henri-Mondor, AP-HP, Créteil, France
| | - G Ploussard
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Department of urology, La Croix du Sud Hôpital, Quint-Fonsegrives, France
| | - C Dariane
- Comité de Cancérologie de l'Association Française d'Urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France; Service d'urologie, Hôpital Européen Georges-Pompidou, AP-HP Centre, Université de Paris, 20 rue Leblanc, 75015 Paris, France
| |
Collapse
|
3
|
Freton L, Graffeille V, Khene Z, Hascoet J, Mathieu R, Vesval Q, Verhoest G, Bensalah K, Peyronnet B. YV plasty for vesico-urethral anastomosis stenosis by combined robotic and perineal approach and concomitant artificial urinary sphincter implantation. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01465-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
4
|
Haudebert C, Hascoet J, Bryckaert P.E, Freton L, Richard C, Khene Z.E, Voiry C, Samson E, Mathieu R, Verhoest G, Bensalah K, Manunta A, Peyronnet B. Robot-assisted intracorporeal Monti catheterizable channel. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01439-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
5
|
Bourgeno HA, Richard C, El Akri M, Hascoet J, Haudebert C, Freton L, Bensalah K, Mathieu R, Peyronnet B. Robot-assisted bladder neck artificial urinary sphincter implantation in male patient with spinal cord traumatism incontinence. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01445-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
6
|
Lebâcle C, Irani J, Legeais D, Doizi S, Bensalah K, Mathieu R, Phé V, Pignot G, Madec FX. Les complications chirurgicales en urologie adulte : chirurgie des organes génitaux externes. Prog Urol 2022; 32:988-997. [DOI: 10.1016/j.purol.2022.09.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2022] [Revised: 09/06/2022] [Accepted: 09/08/2022] [Indexed: 11/21/2022]
|
7
|
Irani J, Bart S, Avrillon V, Pogu B, Madec F, Doizi S, Bensalah K, Mathieu R, Phé V, Pignot G, Lebacle C, Legeais D. Les complications en chirurgie urologique. L’urologue acteur de la gestion des risques. Prog Urol 2022; 32:998-1008. [DOI: 10.1016/j.purol.2022.08.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2022] [Accepted: 08/11/2022] [Indexed: 11/21/2022]
|
8
|
Phe V, Pignot G, Legeais D, Bensalah K, Mathieu R, Lebacle C, Madec FX, Doizi S, Irani J. Les complications chirurgicales en urologie adulte : chirurgie du pelvis et du périnée. Prog Urol 2022; 32:977-987. [DOI: 10.1016/j.purol.2022.08.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2022] [Accepted: 08/11/2022] [Indexed: 11/21/2022]
|
9
|
Mathieu R, Doizi S, Bensalah K, Lebacle C, Legeais D, Madec FX, Phe V, Pignot G, Irani J. Les complications chirurgicales en urologie adulte : chirurgie de la prostate. Prog Urol 2022; 32:953-965. [DOI: 10.1016/j.purol.2022.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2022] [Accepted: 09/05/2022] [Indexed: 11/21/2022]
|
10
|
Corbel A, Leroy V, Vesval Q, Rébillard A, Mathieu R. [Connected APA tools and prostate cancer: Literature review and experience feedback]. Prog Urol 2022; 32:880-887. [PMID: 36280376 DOI: 10.1016/j.purol.2022.09.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Accepted: 09/09/2022] [Indexed: 06/16/2023]
Abstract
Adapted physical activity (APA) appears to be essential for supportive care in oncology. It helps to reduce different side effects inherent to treatment and disease (e.g., fatigue, sarcopenia, balance problems) and could have an impact on patients' survival. However, it is not systematically implemented in daily practice and still too few patients reach the recommendations of physical activity. New tools, such as digital and connected ones, are now developed to overcome barriers to the implementation and daily practice of physical activity (e.g., distance between home and hospital). The aim of this article was to provide an overview of different connected tools that offer exercise training and monitoring programmes in prostate cancer.
Collapse
Affiliation(s)
- A Corbel
- Laboratoire « Mouvement, Sport, Santé » (EA 7470), université Rennes, campus de Ker Lann, Bruz, France.
| | - V Leroy
- Service d'urologie, centre hospitalier universitaire de Rennes, Rennes, France
| | - Q Vesval
- Service d'urologie, centre hospitalier universitaire de Rennes, Rennes, France
| | - A Rébillard
- Laboratoire « Mouvement, Sport, Santé » (EA 7470), université Rennes, campus de Ker Lann, Bruz, France
| | - R Mathieu
- Service d'urologie, centre hospitalier universitaire de Rennes, Rennes, France
| |
Collapse
|
11
|
Bensalah K, Pignot G, Legeais D, Madec FX, Lebacle C, Doizi S, Phé V, Mathieu R, Irani J. Les complications de la néphrectomie totale et de la néphrectomie partielle : quelles sont-elles, comment les prévenir et les prendre en charge ? Prog Urol 2022; 32:928-939. [DOI: 10.1016/j.purol.2022.09.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Accepted: 09/08/2022] [Indexed: 11/21/2022]
|
12
|
Goujon A, Khene ZE, Thenault R, Vigneau C, Peyronnet B, Belabbas D, Guérin S, Chemouny J, Gasmi A, Verhoest G, Shariat S, Bensalah K, Mathieu R. Contrast-enhanced CT texture analysis for the prediction of delayed graft function following kidney transplantation from cadaveric donors. Prog Urol 2022; 32:868-874. [DOI: 10.1016/j.purol.2022.07.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Revised: 06/09/2022] [Accepted: 07/11/2022] [Indexed: 10/15/2022]
|
13
|
Joshi DC, Gebresenbut GH, Fischer A, Rydh A, Häussermann U, Nordblad P, Mathieu R. 2D crystal structure and anisotropic magnetism of GdAu 6.75-xAl 0.5+x (x ≈ 0.54). Sci Rep 2022; 12:13141. [PMID: 35907933 PMCID: PMC9338926 DOI: 10.1038/s41598-022-17068-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2022] [Accepted: 07/20/2022] [Indexed: 12/04/2022] Open
Abstract
Exploration of the gold-rich part of the ternary Gd–Au–Al system afforded the intermetallic compound GdAu6.75−xAl0.5+x (x ≈ 0.54) which was structurally characterized by single crystal X-ray diffraction (Pnma, a = 18.7847(4) Å, b = 23.8208(5) Å, c = 5.3010(1) Å). GdAu6.75−xAl0.5+x crystallizes in a previously unknown structure type featuring layers of Gd2(Au, Al)29 and Gd2(Au, Al)28 clusters which are arranged as in a close-packing parallel to the ac plane. The Gd substructure corresponds to slightly corrugated 36 nets (dGd–Gd = 5.30–5.41 Å) which are stacked on top of each other along the b direction with alternating short (5.4, 5.6 Å, within layers) and long distances (6.4 Å, between layers). The title compound has been discussed with respect to a quasicrystal approximant (1/1 AC) GdAu5.3Al in the same system. The magnetic properties of GdAu6.75−xAl0.5+x were found to be reminiscent to those of some ternary ACs, with sharp peaks in the temperature dependent magnetization, and metamagnetic-like transitions. The material becomes antiferromagnetic below 25 K; magnetometry results suggest that the antiferromagnetic state is composed of ferromagnetic ac planes, coupled antiferromagnetically along the b direction.
Collapse
Affiliation(s)
- D C Joshi
- Department of Materials Science and Engineering, Uppsala University, Box 35, 751 03, Uppsala, Sweden.
| | - G H Gebresenbut
- Department of Chemistry-Ångström Laboratory, Uppsala University, 751 21, Uppsala, Sweden
| | - A Fischer
- Institute of Physics, Augsburg University, 86159, Augsburg, Germany
| | - A Rydh
- Department of Physics, Stockholm University, 106 91, Stockholm, Sweden
| | - U Häussermann
- Department of Materials and Environmental Chemistry, Stockholm University, 106 91, Stockholm, Sweden
| | - P Nordblad
- Department of Materials Science and Engineering, Uppsala University, Box 35, 751 03, Uppsala, Sweden
| | - R Mathieu
- Department of Materials Science and Engineering, Uppsala University, Box 35, 751 03, Uppsala, Sweden.
| |
Collapse
|
14
|
Baboudjian M, Gauthé M, Barret E, Brureau L, Rocchi P, Créhange G, Dariane C, Fiard G, Fromont G, Beauval JB, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Ploussard G. How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ? Prog Urol 2022; 32:6S43-6S53. [PMID: 36719646 DOI: 10.1016/s1166-7087(22)00174-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
INTRODUCTION The aim of this narrative review conducted by the Prostate Cancer Committee of the French Association of Urology (CC-AFU) was to provide an update on the current evidence for the impact of PET/CT in the management of men with non-metastatic castration-resistant prostate cancer (nmCRPC). MATERIAL AND METHODS This review is based on data available in the literature on PET/CT imaging for staging nmCRPC patients. A PubMed search and narrative review of the data were performed in March 2022. Only articles in French or English were considered. RESULTS Current guidelines recommend bone scan and CT scan as standard imaging modalities for staging and follow-up of patients with nmCRPC. Nearly one-third of asymptomatic patients with presumed nmCRPC ultimately have metastatic disease on conventional imaging. Increasing reports have shown that conventional imaging has limited accuracy in detecting metastatic disease in nmCRPC patients, leading to the development of next-generation imaging techniques. In a retrospective study, 18F-choline PET/CT detected distant metastases in 27/58 high-risk nmCRPC patients with prior negative conventional imaging. The implementation of radiolabeled ligands of the prostate-specific membrane antigen (PSMA) PET/CT in staging strategy has resulted in metastasis detection in 45% to 98% of patients with presumptive nmCRPC on conventional imaging. Such an early diagnosis of metastatic CRPC may allow patients to be referred for metastasis-directed therapies (i.e. stereotactic body radiotherapy), aimed at prolonging the efficacy of systemic therapies and improving clinical outcomes. However, current data are not strong enough to recommend this strategy, which must be properly evaluated in clinical trials. Indeed, the use of molecular imaging may lead to inappropriate undertreatment if the second-generation androgen receptor inhibitors (darolutamide, enzalutamide, apalutamide), which prolong life, are not used in the subgroup of patients with high PSA velocity (PSA doubling time <10 months). CONCLUSION Implementation of PSMA-PET/CT in the staging strategy would result in a migration of disease stage to extra-pelvic, M1 disease in at least half of presumed nmCRPC patients. The unprecedented accuracy of PSMA-PET/CT may pave the way for a more personalized treatment strategy. However, no data yet support this strategy for all nmCRPC patients as no oncologic benefit of early detection of M1 disease or MDT has been demonstrated. © 2022 Elsevier Masson SAS. All rights reserved.
Collapse
Affiliation(s)
- M Baboudjian
- Department of Urology, APHM, North Academic Hospital, Marseille, France; Marseille Cancerology Research Center-Inserm UMR 1068, Aix-Marseille Université U105-CNRS UMR 7258, CERIMED Bât.10A - 27 Boulevard Jean Moulin - 13005 Marseille, France; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain.
| | - M Gauthé
- Department of Nuclear Medicine, Scintep - Institut Daniel Hollard, Grenoble, France
| | - E Barret
- Department of Urology, Institut Mutualiste Montsouris, Paris, France
| | - L Brureau
- Department of Urology, CHU de Pointe-à-Pitre, University of Antilles, University of Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-97110 Pointe-à-Pitre, France
| | - P Rocchi
- Marseille Cancerology Research Center-Inserm UMR 1068, Aix-Marseille Université U105-CNRS UMR 7258, CERIMED Bât.10A - 27 Boulevard Jean Moulin - 13005 Marseille, France
| | - G Créhange
- Department of Radiotherapy, Institut Curie, Paris, France
| | - C Dariane
- Department of Urology, Hôpital européen Georges-Pompidou, APHP, Paris - Paris University - U1151 Inserm-INEM, Necker, Paris, France
| | - G Fiard
- Department of Urology, Grenoble Alpes University Hospital, Université Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, Grenoble, France
| | - G Fromont
- Department of Pathology, CHRU Tours, Tours, France
| | - J-B Beauval
- Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France
| | - R Mathieu
- Department of Urology, CHU Rennes, Rennes, France
| | - R Renard-Penna
- Sorbonne University, AP-HP, Radiology, Pitie-Salpetriere Hospital, F-75013 Paris, France
| | - G Roubaud
- Department of Medical Oncology, Institut Bergonié, 33000 Bordeaux, France
| | - A Ruffion
- Service d'urologie Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France; Equipe 2 - Centre d'Innovation en cancérologie de Lyon (EA 3738 CICLY) - Faculté de médecine Lyon Sud - Université Lyon 1
| | - P Sargos
- Department of Radiotherapy, Institut Bergonié, 33000 Bordeaux, France
| | - M Rouprêt
- Sorbonne University, GRC 5 Predictive Onco-Uro, AP-HP, Urology, Pitie-Salpetriere Hospital, F-75013 Paris, France
| | - G Ploussard
- Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France; Department of Urology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France On behalf of the Prostate Cancer Committee of the Association Française d'Urologie (CC-AFU)
| |
Collapse
|
15
|
Lasserre M, Sargos P, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Rouprêt M, Ploussard G, Gauthé M. Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patients. Prog Urol 2022; 32:6S33-6S42. [PMID: 36719645 DOI: 10.1016/s1166-7087(22)00173-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Patients treated by radical prostatectomy (RP) for localized prostate cancer (PCa) may experience biochemical recurrence (BCR) in approximately 30% of cases. Recently, advances in imaging modalities and in particular Positron-Emission Tomography with computed tomography (PET/CT) imaging allow for better detection and characterization of lesions outside the prostatic bed at recurrence. Thus, treatment at BCR can be significantly improved by a tailored strategy based on new generation imaging. A more precise and accurate staging of the disease at recurrence paves the way to more appropriate treatment, potentially translating into better survival outcomes of these patients. This review therefore highlights the interest of PET/CT at the time of BCR, its superiority over standard imaging in terms of staging, and its impact on guiding the different therapeutic possibilities depending on the site, number, and volumes of recurrence. Indeed, we will discuss below about different strategies and their indications: salvage radiotherapy of the prostate bed, systemic therapies, stereotactic body radiotherapy and others therapeutical strategies. The various innovative approaches based on PET/CT implementation are partly underway within protocol trials to prove their benefits on clinically meaningful endpoints. © 2022 Elsevier Masson SAS. All rights reserved.
Collapse
Affiliation(s)
- M Lasserre
- Department of Medical oncology, Institut Bergonié, Bordeaux
| | - P Sargos
- Department of Radiation Oncology, Institut Bergonié, Bordeaux.
| | - E Barret
- Department of Urology, Institut Mutualiste Montsouris, 75014 Paris
| | - J-B Beauval
- Department of Urology, La Croix du Sud Hospital, 31445 Quint Fonsegrives, France
| | - L Brureau
- Department of Urology, CHU de Pointe-à-Pitre, University of Antilles, Inserm, EHESP, Irset-UMR_S 1085, 97110 Pointe-à-Pitre, France
| | - G Créhange
- Department of Radiation Oncology Curie Institute, 75005 Paris
| | - C Dariane
- Department of Urology, Hôpital européen Georges-Pompidou, APHP, Paris-Paris University-U1151 Inserm-INEM, Necker, 75015 Paris
| | - G Fiard
- Department of Urology, Grenoble Alpes University Hospital, Université Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000 Grenoble, France
| | - G Fromont
- Department of Pathology, CHRU, 37000 Tours, France
| | - R Mathieu
- Department of Urology, CHU Rennes, 35000 Rennes, France
| | - R Renard-Penna
- Radiology, Pitie-Salpetriere Hospital, Sorbonne University, AP-HP, 75013 Paris, France
| | - G Roubaud
- Department of Medical oncology, Institut Bergonié, Bordeaux
| | - A Ruffion
- Service d'urologie Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Equipe 2 - Centre d'Innovation en cancérologie de Lyon (EA 3738 CICLY) - Faculté de médecine Lyon Sud - Université Lyon 1, 69000 Lyon, France
| | - M Rouprêt
- GRC 5 Predictive Onco-Uro, Urology, Pitie-Salpetriere Hospital, Sorbonne University, AP-HP, 75013 Paris
| | - G Ploussard
- Department of Urology, La Croix du Sud Hospital, 31445 Quint Fonsegrives, France; Department of Urology, CHU de Pointe-à-Pitre, University of Antilles, Inserm, EHESP, Irset-UMR_S 1085, 97110 Pointe-à-Pitre, France; Department of Radiation Oncology Curie Institute, 75005 Paris; Department of Urology, Hôpital européen Georges-Pompidou, APHP, Paris-Paris University-U1151 Inserm-INEM, Necker, 75015 Paris; Department of Urology, Grenoble Alpes University Hospital, Université Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000 Grenoble, France; Department of Pathology, CHRU, 37000 Tours, France; Department of Urology, CHU Rennes, 35000 Rennes, France; Radiology, Pitie-Salpetriere Hospital, Sorbonne University, AP-HP, 75013 Paris, France; Service d'urologie Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Equipe 2 - Centre d'Innovation en cancérologie de Lyon (EA 3738 CICLY) - Faculté de médecine Lyon Sud - Université Lyon 1, 69000 Lyon, France; GRC 5 Predictive Onco-Uro, Urology, Pitie-Salpetriere Hospital, Sorbonne University, AP-HP, 75013 Paris; Institut Universitaire du Cancer Oncopole, 31000 Toulouse, France
| | - M Gauthé
- Department of Nuclear medicine, Scintep, 38000 Grenoble
| |
Collapse
|
16
|
Baboudjian M, Beauval JB, Barret E, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Ploussard G. Avancées récentes dans la prise en charge du cancer de la prostate localisé à haut risque : mise au point par le Comité Prostate de l’Association française d’urologie. Prog Urol 2022; 32:623-634. [DOI: 10.1016/j.purol.2022.04.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Revised: 04/05/2022] [Accepted: 04/28/2022] [Indexed: 10/18/2022]
|
17
|
Gasmi A, Khene ZE, Guérin S, Bensalah K, Peyronnet B, Mathieu R, Roupret M, Enrique R, Pradère B, Misrai V. Propensity-score analysis comparing perioperative and functional outcomes between XPS 180 W-photovaporization and GreenLight laser enucleation of the prostate: Reasons to discard vaporization and move to enucleation. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00960-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
18
|
Freton L, Graffeille V, Khene Z, Hascoet J, Verhoest G, Mathieu R, Vesval Q, Zhao L, Bensalah K, Peyronnet B. Robotic YV plasty for bladder neck vs. vesico-urethral anastomotic stricture. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00938-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
19
|
Quhal F, Rajwa P, Laukhtina E, Mostafai H, Pradere B, Gontero P, Mathieu R, Briganti A, Heidenreich A, Shariat S. The role of lymph node dissection in patients undergoing salvage radical prostatectomy for radiation recurrent prostate cancer. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01044-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
20
|
Richard C, Pourchasse M, Freton L, Esvan M, Ravel C, Peyronnet B, Mathieu R, Chhor S. Male contraception: What do women think? Prog Urol 2021; 32:276-283. [PMID: 34924309 DOI: 10.1016/j.purol.2021.11.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Revised: 10/29/2021] [Accepted: 11/21/2021] [Indexed: 10/19/2022]
Abstract
INTRODUCTION Women currently bear the most responsibility in contraception, with a wide choice of methods, while only a few existing male contraceptives are available. However, it has been shown that men are willing to get involved in birth control and to control their own fertility. Our research was focused on female population and a survey was carried out to explore women's perceptions of male contraception. METHODS An observational quantitative cross-sectional study using a self-administered-questionnaire was carried out between November 2019 and February 2020. All women aged from 16-years-old to menopause completing the questionnaire were included. Descriptive statistical analyses were conducted, qualitative variables were expressed as counts and frequency. RESULTS In total, 379 interpretable completed questionnaires were included. Among the women, 69.7% were in favour of letting men deal with contraception, without referring to a specific method. After having been made aware of the medical information concerning existing male contraceptives and those in development, the proportion of women in favour dropped to 46.7%. The most acceptable method for a majority of women was the male pill, which is still being developed. The majority (78.4%) of the women in our survey felt insufficiently informed about male contraception. DISCUSSION In our study, women seemed to want to share contraceptive responsibility with men, but the lack of information and of acceptable contraception methods available remained an obstacle. Although larger-scale studies are needed to confirm these results, the development of a wider range of male contraception methods seems to be what both men and women have long been expecting.
Collapse
Affiliation(s)
- C Richard
- Department of Urology, University of Rennes, Rennes, France.
| | - M Pourchasse
- Department of General Medicine, University of Rennes, Rennes, France
| | - L Freton
- Department of Urology, University of Rennes, Rennes, France
| | - M Esvan
- Clinical Investigation Department, University of Rennes, Rennes, France
| | - C Ravel
- CECOS, University of Rennes, Rennes, France
| | - B Peyronnet
- Department of Urology, University of Rennes, Rennes, France
| | - R Mathieu
- Department of Urology, University of Rennes, Rennes, France
| | - S Chhor
- Department of General Medicine, University of Rennes, Rennes, France; Clinical Investigation Department, University of Rennes, Rennes, France
| |
Collapse
|
21
|
Dupuis H, Khene Z, Verhoest G, Mathieu R, Peyronnet B, Bensalah K. Néphrectomie partielle robot-assistée pour les tumeurs CT2 : morbidité, résultats oncologiques et fonctionnels. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
22
|
Lainé-Caroff P, Bruyère F, Mathieu R, Monléon L, Brunereau L, Fromont G, Pradere B. Impact de différentes mesures de la graisse pré-prostatique sur l’agressivité du cancer de la prostate. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
23
|
Neveu P, Ouzaid I, Roumiguié M, Moschini M, Mathieu R, Verhoest G, Shariat S, Hermieu J, Xylinas E. Impact de la taille tumorale sur le pronostic des tumeurs de la voie excrétrice urinaire supérieure de bas risque. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
24
|
Freton L, Richard C, Zhao L, Graffeille V, Thenault R, Hascoet J, Verhoest G, Khene Z, Bensalah K, Mathieu R, Peyronnet B. Plastie YV de sténose d’anastomose urétrovésicale par voie combinée robotique et périnéale associé à la pose d’un sphincter urinaire artificiel. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
25
|
Richard C, Pourchasse M, Freton L, Esvan M, Ravel C, Peyronnet B, Mathieu R, Chhor S. Contraception masculine : qu’en pensent les femmes ? Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
26
|
Haudebert C, Hascoet J, Bryckaert P, Richard C, Freton L, Khene Z, Voiry C, Samson E, Mathieu R, Verhoest G, Bensalah K, Manunta A, Peyronnet B. Cystostomie continente de type Mitrofanoff (appendicovésicostomie) par voie cœlioscopique robot-assistée. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
27
|
Freton L, Graffeille V, Zhao L, Richard C, Hascoet J, Jeanne Julien A, Manunta A, Bensalah K, Mathieu R, Peyronnet B. Greffe de muqueuse buccale par voie robotique transvésicale pour récidive de sclérose de col vésical. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
28
|
Scailteux L, Despas F, Balusson F, Campillo-Gimenez B, Mathieu R, Vincendeau S, Happe A, Nowak E, Kerbrat S, Oger E. Hospitalisation pour évènements indésirables sous abiratérone ou enzalutamide chez des patients avec cancer de prostate résistant à la castration : étude française sur base de données médico-administratives. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
29
|
Haudebert C, Richard C, Manunta A, Khene Z, Graffeille V, Hascoet J, Verhoest G, Bensalah K, Mathieu R, Peyronnet B, Freton L. Réalignement endoscopique précoce des ruptures urétrales post-traumatiques chez l’Homme. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
30
|
Freton L, Khene ZE, Richard C, Mathieu R, Alimi Q, Duval E, Vassal L, Bertheuil N, Aillet S, Bonnet F, Ravel C, Guenego A, Travers D, Morel-Journel N, Hascoet J, Peyronnet B. [Self-assessment of healthcare workers regarding the management of trans people in a university hospital]. Prog Urol 2021; 31:1108-1114. [PMID: 34147357 DOI: 10.1016/j.purol.2021.03.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2020] [Revised: 02/15/2021] [Accepted: 03/08/2021] [Indexed: 01/26/2023]
Abstract
INTRODUCTION Trans people face more barriers when seeking healthcare than the cisgender population probably due to a lack of knowledge, education and comfort of healthcare workers. The purpose of this study was to assess the knowledge and comfort felt by healthcare professionals in managing trans people in a French university hospital. METHODS A self-questionnaire was emailed to healthcare professionals working in departments usually involved in the care of trans people in a French university hospital "not specialized" in medical and surgical gender transition. The questionnaire included demographic questions and Likert scales regarding their knowledge and comfort in taking care of trans people. Responses on the 7-point Likert scales were categorized into "low", "medium" and "high" groups, and responses on the 5-point Likert scales were categorized into "in favour", "neutral" and "against" groups. RESULTS One hundred and two (29%) healthcare professionals answered the questionnaire. Half worked in surgical departments (urology, plastic surgery, gynecology), 24% worked in medical departments (endocrinology, reproductive medicine, cytogenetics) and 26% worked in psychiatry. The majority (60.3%) rated their level of knowledge as "low" and 39.7% as "medium". Sixteen percent rated their level of comfort in managing trans people as "low", 72.5% as "medium" and 11.5% as "high". A majority (77.5%) were in favor of having the costs of gender transition care covered by the national health insurance system, 16.4% were neutral and 6% were against this idea. Feelings about surgical and hormonal gender transition were overwhelmingly (96.4%) in favour or neutral and 91% were willing to get more training and education to manage trans people. CONCLUSION The lack of comfort felt by healthcare professionals in university hospital in managing trans people seems to be related to a lack of knowledge and training in that field and not to a disagreement with the need of transgender healthcare. LEVEL OF EVIDENCE 3.
Collapse
Affiliation(s)
- L Freton
- Université de Rennes, urologie, CHU Rennes, Rennes, France.
| | - Z-E Khene
- Université de Rennes, urologie, CHU Rennes, Rennes, France
| | - C Richard
- Université de Rennes, urologie, CHU Rennes, Rennes, France
| | - R Mathieu
- Université de Rennes, urologie, CHU Rennes, Rennes, France
| | - Q Alimi
- Université de Rennes, urologie, CHU Rennes, Rennes, France
| | - E Duval
- Réseau de Santé Trans, Rennes, France
| | - L Vassal
- Réseau de Santé Trans, Rennes, France
| | - N Bertheuil
- Université de Rennes, chirurgie plastique et reconstructrice, CHU Rennes, Rennes, France
| | - S Aillet
- Université de Rennes, chirurgie plastique et reconstructrice, CHU Rennes, Rennes, France
| | - F Bonnet
- Université de Rennes, endocrinologie, CHU Rennes, Rennes, France
| | - C Ravel
- Université de Rennes, laboratoire de biologie de la reproduction-CECOS, CHU Rennes, Rennes, France
| | - A Guenego
- Université de Rennes, endocrinologie, CHU Rennes, Rennes, France
| | - D Travers
- Université de Rennes, psychiatrie, CHU Rennes, Rennes, France
| | - N Morel-Journel
- Université de Lyon, urologie, Hospices Civils de Lyon, Lyon, France
| | - J Hascoet
- Université de Rennes, urologie, CHU Rennes, Rennes, France
| | - B Peyronnet
- Université de Rennes, urologie, CHU Rennes, Rennes, France
| |
Collapse
|
31
|
Thenault R, Beuzit L, Rioux-Leclercq N, Khene ZE, Gasmi A, Peyronnet B, Bensalah K, Mathieu R. Improving intermediate risk classification of prostate cancer with radiomics features. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01304-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
32
|
Freton L, Richard C, Hascoet J, Khene ZE, Alimi Q, Graffeille V, Verhoest G, Mathieu R, Manunta A, Zhao L, Bensalah K, Peyronnet B. Robotic YV plasty for bladder neck contracture or vesico-urethral anastomosis stenosis in a French university hospital: Preliminary results. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00749-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
33
|
Thenault R, Beuzit L, Gasmi A, Bensalah K, Peyronnet B, Khene ZE, Mathieu R. Evaluation of radiomics in the prediction of the stage and grade of localized prostate cancer: What benefits are expected? Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01307-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
34
|
Rozet F, Mongiat-Artus P, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mathieu R, Ploussard G, Renard-Penna R, Brenot-Rossi I, Bruyere F, Cochet A, Crehange G, Cussenot O, Lebret T, Rebillard X, Soulié M, Brureau L, Méjean A. Corrigendum to "French ccAFU guidelines-update 2020-2022: Prostate cancer" [Prog. Urol 30 (12 S) (2020), pp S136-S251]. Prog Urol 2021; 31:381-382. [PMID: 33941457 DOI: 10.1016/j.purol.2021.04.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- F Rozet
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France; Institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.
| | - P Mongiat-Artus
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - C Hennequin
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - J B Beauval
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - P Beuzeboc
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - L Cormier
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Fromont-Hankard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - R Mathieu
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Ploussard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - R Renard-Penna
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - I Brenot-Rossi
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - F Bruyere
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - A Cochet
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Crehange
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - O Cussenot
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - T Lebret
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - X Rebillard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - M Soulié
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - L Brureau
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - A Méjean
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| |
Collapse
|
35
|
Peddis D, Trohidou KN, Vasilakaki M, Margaris G, Bellusci M, Varsano F, Hudl M, Yaacoub N, Fiorani D, Nordblad P, Mathieu R. Memory and superposition in a superspin glass. Sci Rep 2021; 11:7743. [PMID: 33833313 PMCID: PMC8032676 DOI: 10.1038/s41598-021-87345-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Accepted: 03/26/2021] [Indexed: 11/25/2022] Open
Abstract
The non-equilibrium dynamics of the superspin glass state of a dense assembly of ~ 2 nm MnFe2O4 nanoparticles was investigated by means of magnetization, ac susceptibility and Mössbauer spectroscopy measurements and compared to the results of Monte Carlo simulations for a mesoscopic model that includes particles morphology and interparticle interactions. The zero-field cooled (ZFC), thermoremanent (TRM), and isothermal remanent magnetization (IRM) were recorded after specific cooling protocols and compared to those of archetypal spin glasses and their dimensionality. The system is found to display glassy magnetic features. We illustrate in detail, by a number of experiments, the dynamical properties of the low-temperature superspin glass phase. We observe that these glassy features are quite similar to those of atomic spin glasses. Some differences are observed, and interestingly, the non-atomic nature of the superspin glass is also reflected by an observed superspin dimensionality crossover. Monte Carlo simulations—that explicitly take into account core and surface contributions to the magnetic properties of these ultrasmall nanoparticles in direct contact, as well as interparticle interactions—evidence effects of the interplay between (intraparticle) core/surface exchange coupling and (interparticle) dipolar and exchange interactions.
Collapse
Affiliation(s)
- D Peddis
- Istituto di Struttura della Materia-CNR, 00015, Monterotondo Scalo (RM), Italy. .,Dipartimento di Chimica e Chimica Industriale, Università di Genova, Via Dodecaneso 31, 16146, Genova, Italy.
| | - K N Trohidou
- Institute of Nanoscience and Nanotechnology, NCSR "Demokritos", 153 10 Aghia Paraskevi, Attiki, Greece
| | - M Vasilakaki
- Institute of Nanoscience and Nanotechnology, NCSR "Demokritos", 153 10 Aghia Paraskevi, Attiki, Greece
| | - G Margaris
- Institute of Nanoscience and Nanotechnology, NCSR "Demokritos", 153 10 Aghia Paraskevi, Attiki, Greece
| | - M Bellusci
- Department of Materials and Processes, ENEA, 00123, Rome, CR Casaccia, Italy
| | - F Varsano
- Department of Materials and Processes, ENEA, 00123, Rome, CR Casaccia, Italy
| | - M Hudl
- Department of Physics, Stockholm University, 106 91, Stockholm, Sweden
| | - N Yaacoub
- Institut des Molécules et Matériaux du Mans, UMR CNRS 6283, Le Mans Université, 72085, Le Mans Cedex 9, France
| | - D Fiorani
- Istituto di Struttura della Materia-CNR, 00015, Monterotondo Scalo (RM), Italy
| | - P Nordblad
- Department of Materials Science and Engineering, Uppsala University, Box 35, 751 03, Uppsala, Sweden
| | - R Mathieu
- Department of Materials Science and Engineering, Uppsala University, Box 35, 751 03, Uppsala, Sweden.
| |
Collapse
|
36
|
Rozet F, Mongiat-Artus P, Ploussard G, Rouprêt M, Cacoub P, Fournier G, Mathieu R. [Update on the risk of corticosterone therapy in combination with abiraterone acetate during the COVID-19 pandemic]. Prog Urol 2021; 31:243-244. [PMID: 33468416 PMCID: PMC7836627 DOI: 10.1016/j.purol.2020.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Accepted: 12/03/2020] [Indexed: 11/26/2022]
Affiliation(s)
- F Rozet
- Institut mutualiste Montsouris, université de Paris, 42, boulevard Jourdan, 75014 Paris, France.
| | - P Mongiat-Artus
- Hôpital Saint-Louis, université de Paris, 1, avenue Claude-Vellefaux, 75010 Paris, France
| | - G Ploussard
- Clinique La Croix du Sud, 52, chemin de Ribaute, 31130 Quint-Fonsegrives, France
| | - M Rouprêt
- Hôpital Pitié-Salpêtrière, université Paris Sorbonne, 47-83, boulevard de l'Hôpital, 75013 Paris, France
| | - P Cacoub
- Hôpital Pitié-Salpêtrière, université Paris Sorbonne, 47-83, boulevard de l'Hôpital, 75013 Paris, France
| | - G Fournier
- Hôpital de La Cavale-Blanche, université de Bretagne occidentale, boulevard Tanguy-Prigent, 29200 Brest, France
| | - R Mathieu
- Hôpital Pontchaillou, université Rennes 1, 2, rue Henri-le-Guilloux, 35000 Rennes, France
| |
Collapse
|
37
|
Yang Y, Johansson M, Wiorek A, Tarakina NV, Sayed F, Mathieu R, Jonsson M, Soroka IL. Gamma-radiation induced synthesis of freestanding nickel nanoparticles. Dalton Trans 2021; 50:376-383. [PMID: 33320122 DOI: 10.1039/d0dt03223a] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A versatile method to produce metallic nickel nanoparticles is demonstrated. Metallic Ni nanoparticles have been synthesized from aqueous solution of NiCl2 using γ-radiation induced reduction. To prevent Ni re-oxidation, post-irradiation treatment was elaborated. Structural and compositional analyses were executed using X-ray diffraction, transmission electron microscopy and X-ray photoelectron spectroscopy. These studies reveal that the synthesized material consists of fcc Ni particles having size of 3.47 ± 0.71 nm. The nanoparticles have a tendency to agglomerate to the larger clusters. The latter are partially oxidized to form thin amorphous/poor-crystalline Ni(OH)2/NiO layers at the surface. Magnetization measurements demonstrate that the nanomaterial exhibit ferromagnetic-like behaviour with magnetization 30% lower than that in bulk Ni. The large active surface area (ECSA, 39.2 m2 g-1) and good electrochemical reversibility, confirmed by the electrochemical studies, make the synthesized material a potential candidate as an active component for energy storage devices.
Collapse
Affiliation(s)
- Yi Yang
- Department of Chemistry, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, S-100 44 Stockholm, Sweden.
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Verhoest G, Brassier M, Mathieu R, Peyronnet B, Vincendeau S, Manunta A, Bensalah K. Lymphangiome kystique de veine cave inférieure par chirurgie robotique. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.08.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
39
|
Quhal F, Janisch F, Mori K, Lysenko I, Mostafaei H, D`andrea D, Abufaraj M, Mathieu R, Enikeev D, Fajkovic H, Heidenreich A, Shariat S. The significance of De-Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)36200-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
40
|
Kaulanjan K, Buisset J, Lecoent Q, Perrot E, Carton M, Multigner L, Mathieu R, Villers A, Blanchet P, Brureau L. Prédiction de récidive biologique et de l’envahissement ganglionnaire dans le cancer de prostate : comparaison de la performance des principaux scores prédictifs dans deux populations françaises ethno-géographiques différentes. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
41
|
Freton L, Alimi Q, Zhao L, Haudebert C, Bourre T, Mermier M, Laine-Caroff P, Hascoet J, Mathieu R, Manunta A, Bensalah K, Peyronnet B. Plastie yv robotique et lambeau peritonéal pour sténose d’anastomose vésico-urétrale après prostatectomie radicale et radiothérapie. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.08.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
42
|
Richard C, Hascoet J, Mazouin C, Freton L, Tondut L, Dosin G, Manunta A, Khene Z, Mathieu R, Verhoest G, Bensalah K, Peyronnet B. Explantation d’une prothèse de promontofixation par voie transvésicale et exérèse des bras d’une bandelette tvt laparoscopique robot-assistée. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.08.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
43
|
Freton L, Hascoet J, Khene Z, Alimi Q, Mazouin C, Graffeille V, Verhoest G, Mathieu R, Manunta A, Zhao L, Bensalah K, Peyronnet B. Plastie yv et plastie postérieur robotique pour sclérose de col vésical post-pvp. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.08.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
44
|
Bentellis I, El-Akri M, Hascoet J, Alimi Q, Mathieu R, Vincendeau S, Kerdraon J, Voiry C, Manunta A, Peyronnet B. Valeur pronostique de la pression de clôture urétrale obtenue après sphincter urinaire artificiel chez l’homme. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
45
|
Freton L, Khene Z, Hascoet J, Alimi Q, Verhoest G, Mathieu R, Manunta A, Duval E, Vassal L, Berteuil N, Ravel C, Guénégo A, Bensalah K, Peyronnet B. Auto-évaluation de professionnels de santé concernant la prise en charge des patient.e.s transgenres. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
46
|
Richard C, Hascoet J, Mazouin C, Freton L, Dosin G, Buisset J, Graffeille V, Manunta A, Khene Z, Mathieu R, Verhoest G, Bensalah K, Peyronnet B. Cure de fistule vésico-vaginale par voie vaginale avec interposition d’un lambeau de martius en position du jockey. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.08.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
47
|
Kaulanjan K, Thenault R, Leroy V, Khene Z, Mathieu R. Hormonothérapie dans le cancer de la prostate : quel rôle pour l’IDE en 2020 ? Prog Urol 2020; 30:958-963. [DOI: 10.1016/j.purol.2020.09.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2020] [Accepted: 09/24/2020] [Indexed: 10/23/2022]
|
48
|
Surcel C, Mirvald C, Tsaur I, Borgmann H, Heidegger I, Labanaris AP, Sinescu I, Tilki D, Ploussard G, Briganti A, Montorsi F, Mathieu R, Valerio M, Jinga V, Badescu D, Radavoi D, van den Bergh RCN, Gandaglia G, Kretschmer A. Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer. World J Urol 2020; 39:2483-2490. [PMID: 33135127 DOI: 10.1007/s00345-020-03493-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2020] [Accepted: 10/10/2020] [Indexed: 11/30/2022] Open
Abstract
OBJECTIVE To access the feasibility of palliative cystoprostatectomy/pelvic exenteration in patients with bladder/rectal invasion due to prostate cancer (PC). PATIENTS AND METHODS Twenty-five men with cT4 PC were retrospectively identified in the institutional databases of six tertiary referral centers in the last decade. Local invasion was documented by CT or MRI scans and was confirmed by urethrocystoscopy. Oncological therapies, local symptoms, previous local treatments, time from diagnosis to intervention and type of surgical procedure were recorded. Patients were divided into groups: ADT group (12 pts) and 13 pts without any history of previous local/systemic treatments for PCa (nonADT groups). Perioperative complications were classified using the Clavien-Dindo system. Overall survival (OS) was defined as the time from surgery to death from any cause. A Cox regression analysis, stratified for ISUP score and previous hormonal treatment (ADT) was also performed for survival analysis. RESULTS Ileal conduit was the main urinary diversion in both cohorts. For the entire cohort, complication rate was 44%. No significant differences regarding perioperative complications and complication severity between both subgroups were observed (p = 0.2). Median follow-up was 15 months (range 3-41) for the entire cohort with a median survival of 15 months (95% CI 10.1-19.9). In Cox regression analysis stratified for ISUP score, no statistically significant differences in OS in patients with and without previous ADT before cystectomy or exenteration were observed (HR 3.26, 95% CI 0.62-17.23, p = 0.164). CONCLUSION Palliative cystoprostatectomy and pelvic exenteration represent viable treatment options associated with acceptable morbidity and good short-term survival outcome.
Collapse
Affiliation(s)
- C Surcel
- "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.,Department of Urology, Fundeni Clinical Institute, Bucharest, Romania
| | - C Mirvald
- "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. .,Department of Urology, Fundeni Clinical Institute, Bucharest, Romania.
| | - I Tsaur
- Department of Urology, Johannes Gutenberg University Medical Center, Mainz, Germany
| | - H Borgmann
- Department of Urology, Johannes Gutenberg University Medical Center, Mainz, Germany
| | - Isabel Heidegger
- Department of Urology, Medical University Innsbruck, Innsbruck, Austria
| | - A P Labanaris
- Department of Urology, Interbalkan Medical Center, Thessaloniki, Greece
| | - I Sinescu
- "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.,Department of Urology, Fundeni Clinical Institute, Bucharest, Romania
| | - Derya Tilki
- Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany
| | - G Ploussard
- Department of Urology, La Croix du Sud Hospital, Toulouse, France
| | - A Briganti
- Department of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
| | - F Montorsi
- Department of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
| | - R Mathieu
- Department of Urology, CHU Rennes, Rennes, France
| | - M Valerio
- Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
| | - V Jinga
- Urology Department, 'Prof. Dr. Th. Burghele' Clinical Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania
| | - D Badescu
- Urology Department, 'Prof. Dr. Th. Burghele' Clinical Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania
| | - D Radavoi
- Urology Department, 'Prof. Dr. Th. Burghele' Clinical Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania
| | - R C N van den Bergh
- Unit of Urology/Division of Oncology, St Antonius Hospital, Utrecht, Netherlands
| | - G Gandaglia
- Department of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
| | - A Kretschmer
- Department of Urology, Ludwig-Maximilians University of Munich, Munich, Germany
| | | |
Collapse
|
49
|
Dosin G, Mazouin C, Manunta A, Hascoet J, Bensalah K, Verhoest G, Freton L, Mathieu R, Graffeille V, Khene Z, Voiry C, Samson E, Haudebert C, Pradere B, Peyronnet B. Cystectomie et dérivation cutanée non continente par conduit iléal robotique intracorporelle pour vessie neurologique. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.08.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
50
|
Mazouin C, Khene Z, Peyronnet B, Gasmi A, Dosin G, Brassier M, Thi Dang V, Ouzaid I, Larcher A, Roumiguié M, Verhoest G, Pradère B, Shariat S, Mathieu R, Bigot P, Doumerc N, Bensalah K. Prédire la morbidité de la néphrectomie partielle : retour à la simplicité. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|